News

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
The fact that the two are partnering is notable as it comes shortly after a feud between the companies over Hims & Hers’ Super Bowl ad that featured the telehealth company’s compounded GLP-1s.
GMA” caught up with the newly-crowned Super Bowl MVP at Walt Disney World after the Philadelphia Eagles’ big win against the Kansas City Chiefs. The tele-health company Hims & Hers Health is ...
Zacks Equity Research shares Hims & Hers Health HIMS as the Bull of the Day and AST SpaceMobile ASTS as the Bear of the D ...
Hims & Hers Health has emerged as a disruptive ... 35% of conversions through relatable content Brand Campaigns: Super Bowl ads and billboards normalize conversations about sensitive health ...
Hims & Hers Health (HIMS ... driving 35% of conversions through relatable content Brand Campaigns: Super Bowl ads and billboards normalize conversations about sensitive health issues Algorithmic ...
(Hims & Hers Health) Telehealth provider Hims & Hers Health is defending its Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits ...
Hims & Hers projects weight loss business to hit $725M in 2025 despite GLP-1 market shift During the Super Bowl in February ran a controversial ad that featured a montage of junk food, abdominal ...